Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Akebia Therapeutics (AKBA) Non-cash Items (2016 - 2019)

Historic Non-cash Items for Akebia Therapeutics (AKBA) over the last 4 years, with Q4 2019 value amounting to $3.8 million.

  • Akebia Therapeutics' Non-cash Items rose 5987.11% to $3.8 million in Q4 2019 from the same period last year, while for Dec 2019 it was $3.8 million, marking a year-over-year increase of 5987.11%. This contributed to the annual value of $3.8 million for FY2019, which is 4147.98% down from last year.
  • According to the latest figures from Q4 2019, Akebia Therapeutics' Non-cash Items is $3.8 million, which was up 5987.11% from $2.4 million recorded in Q4 2018.
  • Akebia Therapeutics' Non-cash Items' 5-year high stood at $21.9 million during Q4 2017, with a 5-year trough of $2.4 million in Q4 2018.
  • Moreover, its 4-year median value for Non-cash Items was $7.1 million (2016), whereas its average is $9.6 million.
  • Per our database at Business Quant, Akebia Therapeutics' Non-cash Items skyrocketed by 11012.62% in 2017 and then plummeted by 8927.95% in 2018.
  • Akebia Therapeutics' Non-cash Items (Quarter) stood at $10.4 million in 2016, then skyrocketed by 110.13% to $21.9 million in 2017, then tumbled by 89.28% to $2.4 million in 2018, then soared by 59.87% to $3.8 million in 2019.
  • Its Non-cash Items was $3.8 million in Q4 2019, compared to $2.4 million in Q4 2018 and $21.9 million in Q4 2017.